From defining the future of medical technology to researching cures for diseases and changing the way health insurance is delivered, the healthcare companies listed on the New York Stock Exchange are shaping the future of their industry. While they’re on the front lines, our role is behind the scenes; it’s to support this group of innovators and problem solvers by providing the access to capital and other resources public companies need to solve real-world challenges and make a positive impact on their communities. Every year, more healthcare companies turn to us because they know we provide the support they need to launch and manage a public company. Now it’s your turn.
Why the Healthcare Industry is Choosing NYSE
We’re proud to partner with companies that are transforming the future of healthcare. Our network accounts for 71% of the healthcare vertical by market cap and includes companies of all sizes such as Pfizer, J&J, Penumbra, Teladoc, Glaukos, Invitae, Biohaven and Zymeworks.Take a Look at the NYSE Network
The Healthcare sector stocks are 56% more volatile than all other industries, which makes the NYSE market model particularly valuable. Through the support of a Designated Market Maker who personally participates in the trading of your stock, our market model lowers your stock’s volatility and increases liquidity.Evaluate the NYSE Market Model
Whether it’s Arcus Biosciences ringing the NYSE Bell at their IPO, Penumbra sharing their story with the world thanks to 35 networks broadcasting live from the trading floor and syndication to countless others, or a Johnson & Johnson campaign getting increased exposure through our social channels, we offer our companies global visibility with real business results.
They leverage the NYSE’s unique marketing assets to raise brand visibility, reposition brands and support product launches, in addition to using our state-of-the-art conference facilities to host analyst days, conduct board meetings, introduce new leadership, and much more.
Being a public company offers increased access to the capital you need to continue innovating and growing, while also placing new demands on your company. We’ve worked closely with the management teams at NYSE-listed companies to understand their needs and develop efficient solutions that address the needs of their growing public businesses.Look at NYSE Services
What our listed companies are saying
CEO, Biohaven Pharmaceuticals
Executive Chairman, Invitae
CEO, Arcus Biosciences